The guidelines also encouraged countries to ensure access to GLP-1 medications for not only disease management, but also health promotion and prevention policies and interventions for the general population and those who are at higher risk
The peptide works by binding to the melanocortin receptors 1, 3, 4, and 5 (MC1R, MC3R, MC4R, MC5R), with high affinity at MC1R, with the effect of increasing melanin production and tanning in research subjects [1, 2, 3]
All FDA-approved weight loss drugs undergo rigorous testing to ensure they are safe and effective
Furthermore, clinical trials (including CANVAS and CREDENCE) have demonstrated cardiovascular and renal protective effects, with evidence suggesting reduced risk of major adverse cardiovascular events and slowed progression of diabetic kidney disease
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA
Peptide potency drops below 80% after 28 days due to progressive hydrolysis of amide bonds in the peptide backbone